Endpoints News: 20 Under Forty in Biopharma: Sean McClain aims to simplify protein production

Apr 06, 2021

Endpoints News names Sean McClain, CEO and founder of Absci, to its 20 Under Forty in Biopharma list. Read more.

Related Media Highlights

Related Resources

Absci R&D Day 2024

Read More

NeurIPS 2024

Read More

Development of ABS-101: A potential best-in-class anti-TL1A antibody for the treatment of IBD

Read More